AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO

RecruitingNAAges 18 Years - anyAllAcademisch Medisch Centrum - Universiteit van Ams…
💬

In plain words

What the trial is, and whether it could suit you

Rationale: In patients supported with extracorporeal membrane oxygenation (ECMO), transfusion of red blood cells (RBC) is very common. This is possibly due to the application of liberal thresholds and the lack of evidence-based guidelines. Although RBC transfusion can be lifesaving, it is also a risk-bearing intervention with substantial risk for morbidity and mortality in this critically ill population. Also, with increasing scarcity, RBC transfusions are becoming more expensive. Furthermore, in the past decades it has been shown in several critically ill patient populations - not on ECMO - that maintaining a restrictive hemoglobin (Hb) threshold for RBC transfusion is non-inferior, including in cardiothoracic surgery, acute myocardial infarction and septic shock. Therefore, the investigators hypothesize that a restrictive transfusion threshold for RBC is safe to apply in patients on EC

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient is aged 18 years or older; * Is receiving ECMO; * (Deferred) informed consent. Exclusion Criteria: * Not expected to survive for 24 hours when assessed; * Inability to receive blood products; * (Known) decline to blood transfusions (e.g., Jehovah's Witnesses); * Extracorporeal carbon dioxide removal (ECCO2R) using low blood flow devices or pumpless devices (i.e., MINILUNG ®, PrismaLung+); * Received ECMO over 48h before screening for eligibility.
💊

What it tests

  • Red Blood Cell transfusion
📍

Where

14 sites
MedUni Wien
Vienna, Austria
Hôpital Erasme
Brussels, Belgium
KU Leuven, medical IC
Leuven, Belgium
KU Leuven, surgical IC
Leuven, Belgium
CHU Charleroi
Charleroi, Belgium
Medisch Spectrum Twente (MST)
Enschede, Netherlands
Radboudumc
Nijmegen, Netherlands
Maastricht Universitair Medisch Centrum+ (MUMC+)
Maastricht, Netherlands

…and 6 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy